Novartis India Limited (NOVARTIND.BO)
- Previous Close
954.55 - Open
960.00 - Bid 967.05 x --
- Ask 973.00 x --
- Day's Range
957.25 - 988.00 - 52 Week Range
744.95 - 1,248.00 - Volume
21,419 - Avg. Volume
16,524 - Market Cap (intraday)
24.028B - Beta (5Y Monthly) -0.01
- PE Ratio (TTM)
23.81 - EPS (TTM)
40.87 - Earnings Date May 9, 2025
- Forward Dividend & Yield 25.00 (2.57%)
- Ex-Dividend Date Jul 23, 2025
- 1y Target Est
--
Novartis India Limited operates as a healthcare company in India. The company offers therapeutic products in the areas of bone and pain products under the Voveran brand; transplantation immunology products under the Simulect, Certican, Sandimmun, Neoral, and Myfortic brands. It also offers neurosciences products under the Tegrital and Exelon brands. Novartis India Limited was incorporated in 1947 and is based in Mumbai, India. The company is a subsidiary of Novartis AG.
www.novartis.in--
Full Time Employees
March 31
Fiscal Year Ends
Sector
Recent News: NOVARTIND.BO
View MorePerformance Overview: NOVARTIND.BO
Trailing total returns as of 5/23/2025, which may include dividends or other distributions. Benchmark is S&P BSE SENSEX (^BSESN) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: NOVARTIND.BO
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: NOVARTIND.BO
View MoreValuation Measures
Market Cap
24.03B
Enterprise Value
17.59B
Trailing P/E
23.81
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
6.74
Price/Book (mrq)
3.06
Enterprise Value/Revenue
4.94
Enterprise Value/EBITDA
13.19
Financial Highlights
Profitability and Income Statement
Profit Margin
28.32%
Return on Assets (ttm)
6.32%
Return on Equity (ttm)
13.19%
Revenue (ttm)
3.56B
Net Income Avi to Common (ttm)
1.01B
Diluted EPS (ttm)
40.87
Balance Sheet and Cash Flow
Total Cash (mrq)
6.48B
Total Debt/Equity (mrq)
0.64%
Levered Free Cash Flow (ttm)
625.72M